rLVS(delta) capB/Yp F1-V single vector platform vaccine expressing Yersinia pestis F1 and LcrV antigens provides complete protection against lethal respiratory challenge with virulent plague bacilli

By sjmartinez • May 27, 2025

Jia Q, Bowen RA, Masleša-Galić S, Horwitz MA. rLVS ΔcapB/Yp F1-V single vector platform vaccine expressing Yersinia pestis F1 and LcrV antigens provides complete protection against lethal respiratory challenge with virulent plague bacilli. Hum Vaccin Immunother. 2025 Dec;21(1):2507475. doi: 10.1080/21645515.2025.2507475. Epub 2025 May 26. PMID: 40417828.

Tags: bioterrorism, F1, Francisella tularensis, Infectious Diseases, LcrV, LVS ΔcapB, plague, Publications, single vector platform vaccine, Tier 1 select agent, vaccine, Yersinia pestis

Intersecting Vulnerabilities: Depression, Suicidality, and HIV Risk Among Young Mothers in South Africa

Miller AP, Joseph Davey DL, Groenewald C, Filiatreau LM, Petersen Z, van Rooyen H, Essack Z. Intersecting Vulnerabilities: Depression, Suicidality, and HIV Risk Among Young[...]

Atomically Precise Polyanionic Boron Cluster Agents with Broad-Spectrum Antiviral Activity

Wang Y, Arumugam B, Doud E, DeLuca D, Rebelo M, Yang OO, Spokoyny AM. Atomically Precise Polyanionic Boron Cluster Agents with Broad-Spectrum Antiviral Activity. Precis[...]

Don’t Drop the B: Risk of Hepatitis B Virus Infection and Reactivation in the Era of Tenofovir-Sparing Regimens for Treatment and Prevention of HIV

Lee TH, Bhattacharya D, Kim HN. Don't Drop the B: Risk of Hepatitis B Virus Infection and Reactivation in the Era of Tenofovir-Sparing Regimens for[...]